BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9537073)

  • 21. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is interferon an "inducer" of serum amyloid A?
    Maury CP; Enholm E; Teppo AM
    N Engl J Med; 1983 Oct; 309(17):1060-1. PubMed ID: 6621643
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pathogenesis of amyloidosis. The biphasic cellular theory].
    Teilum G
    Ugeskr Laeger; 1969 Feb; 131(8):309-12. PubMed ID: 4181930
    [No Abstract]   [Full Text] [Related]  

  • 25. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.
    Obici L; Raimondi S; Lavatelli F; Bellotti V; Merlini G
    Arthritis Rheum; 2009 Oct; 61(10):1435-40. PubMed ID: 19790131
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
    Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
    J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic options in systemic AL amyloidosis.
    van Gameren II; Lokhorst H; Hazenberg BP; Vellenga E
    Neth J Med; 2004 Apr; 62(4):106-13. PubMed ID: 15255079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic AA-amyloidosis in a European wild boar (Sus scrofa) suffering from generalized tuberculosis.
    Segalés J; Vicente J; Luján L; Toussaint MJ; Gruys E; Gortázar C
    J Vet Med A Physiol Pathol Clin Med; 2005 Apr; 52(3):135-7. PubMed ID: 15836445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The systemic amyloidoses: an overview.
    Falk RH; Skinner M
    Adv Intern Med; 2000; 45():107-37. PubMed ID: 10635047
    [No Abstract]   [Full Text] [Related]  

  • 30. From renal amyloid deposits to the identification of the culprit genes.
    Pirson Y
    J Nephrol; 2003; 16(3):427-30. PubMed ID: 12832746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
    Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
    Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An animal model of vascular amyloidosis.
    Ghiso J; Wisniewski T
    Nat Neurosci; 2004 Sep; 7(9):902-4. PubMed ID: 15332087
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunohistochemical identification of amyloid, using an anti-human serum amyloid P component (SAP) antibody, is possible in ruminants but not in dogs and cats.
    Hartig W; Leifsson PS; Nielsen OL
    J Vet Med A Physiol Pathol Clin Med; 2005 Nov; 52(9):447-53. PubMed ID: 16268955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloidosis in black-footed cats (Felis nigripes).
    Terio KA; O'Brien T; Lamberski N; Famula TR; Munson L
    Vet Pathol; 2008 May; 45(3):393-400. PubMed ID: 18487501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
    J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
    Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of vascular amyloid in scrapie-affected sheep with different genotypes.
    Ligios C; Dexter G; Spiropoulos J; Maestrale C; Carta A; Simmons MM
    J Comp Pathol; 2004 Nov; 131(4):271-6. PubMed ID: 15511535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequencies of the serum amyloid A2 alleles in healthy (Turkish, Azerbaijan and Kazakh) populations.
    Taştan H; Osmanagaoglu O; Tuzun A
    Genetika; 2005 Jul; 41(7):986-9. PubMed ID: 16152805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.